Teva Recalls One Lot Of IDArubicin Hydrochloride Injection :

PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals has initiated a recall of lot 31329657B of IDArubicin Hydrochloride Injection USP 5 mg/5 mL vial in the United States due to the possible presence of

Related Keywords

United States , , Drug Administration , Teva Pharmaceuticals United States Inc , Teva Pharmaceuticals , Hydrochloride Injection , Teva Pharmaceuticals United States , Fresenius Kabi United States , Sodium Acetate Injection , Teva , Recalls , Darubicin , Hydrochloride , Injection ,